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1. Introduction 
The catecholamine-rich, chromaffin-rich chromaffin 
granules are capable of accumulating these amines by 
a process requiring ATP [ 1,2]. This process is inhibited 
by reserpine [ 11, a competitive and reversible inhibitor 
of the catecholamine transporter [3], and also by 
proton ionophores [4]. Moreover, it has been shown 
that the granules contain an ATPase capable of 
generating a electrochemical proton gradient (A&+) 
consisting of a pH gradient (ApH), acid inside 
[5-lo], and a membrane potential (A$). interior 
positive [7,11,12]. These observations strongly suggest 
that the ATP-dependent accumulation is a conse- 
quence of two discrete steps: 
(i) ATP-dependent generation of an electrochemical 
proton gradient; 
(ii) Catecholamine uptake driven by this gradient or 
one of its components (ApH or A$). 
In fact with intact chromaffin granules some corre- 
lations have been found between the magnitude of 
A+ [ 13,141 and ApH [ 141 and the levels of biogenic 
amines taken up. However an obvious drawback of the 
intact granules is that they contain high levels of 
endogenous amines, complexed with ATP and Mg2+ 
[15-171. Studies with chromaffin granule ghosts, 
which makes it possible to study the transport process 
itself, have provided direct evidence for the involve- 
ment of ApH as a driving force for biogenic amine 
transport. Thus, when pH gradients (interior acid) are 
artificially imposed across the ghost membrane, this 
results in a reserpine-sensitive biogenic amine uptake 
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[ 18-201. The ability of A$ to serve as a driving force, 
in addition to ApH, is not clear [18,19,21,22] and 
the concept has in fact been challenged [20]. How- 
ever, artificial imposition of A$ (interior positive) 
causes a small increase in the steady state accumula- 
tion of adrenaline [23]. Similar attempts of our own 
using S-HT, which is transported by the same carrier 
[3], showed only marginal stimulations if any. There- 
fore we defined conditions in which the effect of 
artificially imposed membrane potential, if any, would 
be easier to demonstrate. 
Here, we provide direct evidence for this possibility, 
since it is shown that when an artificial ApH is 
imposed, the accumulation of biogenic amines is 
affected by the polarity of A$. 
2. Materials and methods 
2.1. Chemicals 
5-Hydroxy [G-3H] tryptamine (26.2 Ci/mmol) and 
D,L-[7-3H] noradrenaline hydrochloride (15.2 Ci/ 
mmol) were purchased from New England Nuclear. 
Valinomycin was acquired from Sigma. 
2.2. Preparations 
Chromaffin granule membrane vesicles were 
isolated as in [ 191, except that when Na-loaded 
vesicles were used K-Hepes was replaced with Na- 
Hepes throughout the preparation. Moreover the 
Na-loaded vesicles resuspended in 0.3 M sucrose, 
10 mM Na Hepes (pH 7.5) were centrifuged once 
more and resuspended in a minimal volume at 20-25 mg 
protein/ml before storage in liquid air. Reconstitu- 
tion in the presence of appropriate loading media was 
done as in [24]. 
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2.3. Transport assaq’s 
Membrane vesicles were thawed and loaded with 
either Na- or K-Hepes at pH 6.5 as in [ 191. Aliquots 
(4 ~1) of these vesicles were then diluted into 300 1.11 
assay medium containing 100 mM sucrose, the radio- 
active biogenic amine and either 95 mM Na- or K- 
Hepes (pH 8.5) as indicated in the figure legends. 
Valinomycin (2.5 PM) was added when indicated. 
Reactions were terlninated and radioactivity was 
assayed as in [ 191 except that 0.3 M sucrose con- 
taining 10 mM K-Hepes (pH 8.5) was used as a stop 
solution. 
2.4. Protein determit~ations 
These were performed as in [25]. 
3. Results 
The imposition of ApH by dilution of chromaffin 
granule ghosts loaded with sodium containing buffer 
at pH 6.5 into a potassium containing assay medium 
buffered at pH 8.5 results in a fast accumulation of 
5-HT which reaches a steady state value of -23 pmol/ 
mg protein (fig. 1A) after 1 min. Using the value of 
3.9 pl/mg protein for the intravesicular volume [ 191 
a concentration gradient of -65 is reached. When the 
dilution medium contains valinomycin. a condition 
expected to superimpose a membrane potential 
(interior positive) on top of the ApH, a pronounced 
increase of both initial rate and extent of 5-HT accu- 
mulation is observed and reserpine, a competitive and 
reversible inhibitor of the biogenic amine carrier, 
strongly inhibits the process(fig. 1A). Since artificially 
imposed membrane potentials across this membrane 
decay rather quickly [33] the stimulation of accumu- 
lation is transient. Nevertheless, the concentration 
gradient rises from 65-137, and in the experiment 
depicted in fig.lB an even higher gradient (228-fold) 
is observed. It can be seen that in the latter experi- 
ment valinomycin stimulates 5-HT accumulation only 
under conditions in which A+ is generated ([K’],,, 
> W+lh). 
It is also of interest to note that although valino- 
mycin stimulates the accumulation of 5-HT. the 
decay of this accumulation is accelerated by the 
ionophore. In fact at later times the level of accumula- 
tion in the presence of the ionophore is lower than in 
its absence. Thus it seems that the co-ion permeability, 
in this case potassium, limits the decay of ApH. It 
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F1g.1. Effects of valinomycin and reserpinc on Apll-driven 
5-HT transport with superimposed potassium ion gradient 
(out > in). (A) Sodium-loaded vesicles (101 ~g protein/ 
assay) and the potassium containing assay medium supple- 
mented with 0.09 Mhf 5-[3H]HT (0.5 crCl/assay) were used 
The following additions were made: (- --) none; (W-T) 
valinomycin. 2.5 PM (a-n) reserpine. 2 PM in the latter case 
an aliquot of the vesicles was prcincubated on ice with 
reserpine at the same concentration present in the assay 
medium. (B) Sodium loaded vesicles (64 ~8 protein/assay) 
and the potassium (circles) or sodium (triangles) containing 
assay media were used, both containing 0.09 PM 5-[3H]HT 
(0.5 pCi/assay). The experiments wrrc done m the absence 
(open symbols) or presence (closed symbols) of valinomycin. 
2.5 PM. Since both valinomycm and reserpine stock solu- 
tions were in DMSO controls containmg identical amounts of 
DMSO (1-l .5%) were run and the results were identical to 
those in the absence of DMSO. 
should be stressed that clear and highly reproducible 
stimulations by valinomycin are only observed when 
a ApH of 2 units (acid interior) is imposed. Thus with 
a ApH of 1 unit it was much more difficult to observe 
the effect and with no ApH hardly any effect was seen 
(data not shown). Results similar to those with 5-HT 
are also observed with norepinephrine (fig.2). This is 
to be expected since we have recently shown that all 
biogenic amines are translocated by one carrier [3]. 
This carrier was recently solubilized and recon- 
stituted in our laboratory [24]. Results similar to 
those described above are also obtained using the 
reconstituted system (data not shown). 
Further support for the contention that A$ 
(interior positive) serves as a driving force for biogenic 
amine accumulation is derived from the experiment 
depicted in fig.3. Potassium-loaded vesicles buffered 
at pH 6.5 are diluted into sodium containing media at 
pH 8.5. The addition of valinomycin is expected to 
cause a membrane potential (interior negative) with a 
polarity opposite to that under the experimental con- 
ditions of fig.l,2. It can be seen that under the con- 
ditions of this experiment the addition of the iono- 
phore has opposite consequences for 5-HT accumula- 
tion, a strong inhibition is observed (fig.3). Again the 
9 E effects are consistent with the well-known specificity 
Z. I/ of the ionophore. When the potassium loaded vesicles 
are diluted in potassium containing media, valino- 
mycin does not inhibit. It actually stimulates 5-HT 
accumulation, presumably by charge compensation, 
allowing potassium entry in response to exit of posi- 
tive charge caused by the translocation of S-HT. 
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Fig.2. Effects of valinomycin and reserpine on ApH-driven 
norepinephrine transport with superimposed potassium ion 
gradient (out > in). Sodium loaded vesicles (96 pg protein/ 
assay) and the potassium (circles) or sodium (triangles) con- 
taining assay media supplemented with 0.16 PM [ 3H]nor- 
adrenaline (0.5 pCl/assay) were used. These experiments 
were done in the absence (open symbols) or presence (closed 
symbols) of 2.5 JLM valinomycin. An experiment using the 
same vesicles preincubated with reserpine as above, with 
the potassium containing medium supplemented with 2.5 PM 
valinomycin and 2 PM reserpme is represented by the filled 
squares. 
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4. Discussion 
The effect of an artificially imposed A$ on ApH 
driven 5-HT and norepinephrine transport provides 
direct evidence that both components of the Aj?H+ 
generated by the ATPase represent driving forces for 
biogenic amine transport. The ability of A$ (interior 
positive) to stimulate in the presence of ApH (interior 
acid) is consistent with the polarity of both compo- 
nents generated by the granule membrane ATPase. 
As such the above results exclude the possibility of 
an electroneutral mechanism [ 18-20,221. Instead it 
seems reasonable to postulate that the carrier acts as 
an antiporter translocating the biogenic amine in one 
direction and n protons in the opposite direction 
[ 14,231. 
If the translocated species is the positive form 
n + 1 protons would have to be moved in the opposite 
direction. This means that with a given protonmotive 
force (ApH+) higher concentration ratios of the bio- 
genie amines (ArBA) can be achieved. 
Fern= 1: 
ArBA = 2 (2.3Flog 
[H+lin 
----)+A$ 
[H’lou, 
(1) 
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Fig.3. Effect of valinomycin on ApH driven S-NT transport 
with superimposed potassium ion gradient (in > out). Potas- 
sium-loaded vesicles (28.4 pg protein/assay) and the potas- 
sium (circles) or sodium (triangles) containing assay media 
supplemented with 0.09 PM 5-[“H]HT (0.5 pCi/assay) were 
used. The experiments were done in the absence (open sym- 
bols) or presence (closed symbols) of 2.5 PM valinomycin. 
as opposed to: 
RT [H+lin A/ABA =2.3F- log ____ 
[H+]out 
(2) 
for an electroneutral process. It is possible that the 
maximum ApBA is actually never reached since in 
the absence of carrier biogenic amines can also 
distribute according to ApH [24,26]. There are some 
indications that with ATP-dependent transport values 
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of ApBA higher than those dictated by (2) are 
observed. Thus a concentration gradient of epineph- 
rine of 1100 is observed while under similar con- 
ditions the proton concentration gradient is only 170 
[ 10,191. Also in fig. I concentration ratios higher than 
those dictated by ApH alone are observed notwith- 
standing the fast decay of A$. Accumulation of bio- 
genie amines according to (1) indicates that ApH is 
the dominant component of the driving force. In 
addition, the Aj$+ generated by ATP in the presence 
of chloride is mostly in the form of ApH [ 121. This 
may provide an explanation for the observation that 
valinomycin (collapsing A$) does not inhibit ATP- 
dependent accumulation and that nigericin (collaps- 
ing ApH) does inhibit strongly [18,19]. The higher 
concentration ratios which may be achieved by an 
electrogenic mechanism also may explain the fact 
that reserpine inhibits very strongly even though 
.5-HT and other amines can equilibrate across the 
membrane in the presence of ApH [24,26]. 
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